Theravance, a biopharmaceutical company, has announced that the FDA has accepted for filing the new drug application for telavancin, a novel, bactericidal, once-daily injectable investigational antibiotic, for the
Through this acquisition, Sunwin expects to convert Qufu Shengren’s pharmaceutical production facilities to the production of high grade stevia in approximately three months saving substantial construction time for
In this collaboration, BG Medicine (BGM) will measure levels of Galectin-3 in patients enrolled in the study. Galectin-3 is a biomarker for cardiac remodeling associated with advanced stages
The Moroccan Industrial and Commercial Property Office granted the company its first Moroccan patent, which contains claims to pharmaceutical formulations effective to deliver a pharmaceutical agent across oral
The clinical development plan for MPC-3100 is designed to expedite the drug candidate through the clinical development path. The Phase I trial will assess the safety and pharmacokinetics
Pursuant to the agreement, Avalon will withdraw its nominees for election to the board of directors. The parties have also agreed to add another mutually acceptable independent director
The agreement provides Merck with exclusive global rights to the oral formulation of vernakalant (vernakalant (oral)) for the maintenance of normal heart rhythm in patients with atrial fibrillation,
According to Novartis, Coartem is a fixed-dose combination of two novel antimalarials. It is a highly-effective three-day malaria treatment with cure rates of over 96% even in areas
According to Aurobindo Pharma, finasteride APL tablets 5mg is indicated for the treatment of symptomatic benign prostatic hyperplasia (BPH) in men with enlarged prostrate.
This acquisition will reportedly enable Sanofi-Aventis to become the leading player in the field of generics in Brazil and in Latin America. The closing of the transaction is
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.